Coastwise Capital Group LLC trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 29.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,104 shares of the biopharmaceutical company’s stock after selling 6,668 shares during the quarter. Coastwise Capital Group LLC’s holdings […]
Westwood Holdings Group Inc. lifted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 366,246 shares of the biopharmaceutical company’s stock after buying an additional 52,337 shares during the period. Westwood […]
Platform Technology Partners lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,906 shares of the biopharmaceutical company’s stock after purchasing an additional 2,908 shares during the period. Platform Technology Partners’ […]
Oppenheimer & Co. Inc. reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.3% in the fourth quarter, Holdings Channel reports. The fund owned 192,330 shares of the biopharmaceutical company’s stock after selling 15,254 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Bristol-Myers Squibb were worth $9,868,000 as of […]
Hudson Edge Investment Partners Inc. boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,796 shares of the biopharmaceutical company’s stock after purchasing an additional 15,983 shares during the […]